OBJECTIVE: Feasibility, acceptability, and efficacy of a Dialectical Behavioral Therapy (DBT) -based method developed in Germany were evaluated in a Swedish outpatient psychiatric context. METHOD: Fifty-one adults with ADHD on stable medical treatment or on no medication were randomized to the DBT-based skills training (n=26) or a parallel loosely structured discussion group (n=25). Self-rating scales were administered before randomization and after the treatment. RESULTS:Feasibility and participant satisfaction were good in both groups while skills training was perceived as more logical and effective for ADHD-related problems. The analyses of the individuals who completed the treatment and remained stable with regard to medication (n=19 in skills training; n=18 in control group) showed a significant reduction in ADHD symptoms in the skills training group, but not in the control group. No reduction of comorbidity was observed in any of the groups. CONCLUSIONS: The treatment was feasible in an outpatient psychiatric context, well tolerated, and significantly reduced ADHD symptoms in on-treatment individuals who remained stable regarding medication status.
RCT Entities:
OBJECTIVE: Feasibility, acceptability, and efficacy of a Dialectical Behavioral Therapy (DBT) -based method developed in Germany were evaluated in a Swedish outpatientpsychiatric context. METHOD: Fifty-one adults with ADHD on stable medical treatment or on no medication were randomized to the DBT-based skills training (n=26) or a parallel loosely structured discussion group (n=25). Self-rating scales were administered before randomization and after the treatment. RESULTS: Feasibility and participant satisfaction were good in both groups while skills training was perceived as more logical and effective for ADHD-related problems. The analyses of the individuals who completed the treatment and remained stable with regard to medication (n=19 in skills training; n=18 in control group) showed a significant reduction in ADHD symptoms in the skills training group, but not in the control group. No reduction of comorbidity was observed in any of the groups. CONCLUSIONS: The treatment was feasible in an outpatientpsychiatric context, well tolerated, and significantly reduced ADHD symptoms in on-treatment individuals who remained stable regarding medication status.
Authors: Sven Bölte; Soheil Mahdi; David Coghill; Susan Shur-Fen Gau; Mats Granlund; Martin Holtmann; Sunil Karande; Florence Levy; Luis A Rohde; Wolfgang Segerer; Petrus J de Vries; Melissa Selb Journal: Eur Child Adolesc Psychiatry Date: 2018-02-12 Impact factor: 4.785
Authors: Julia M Geissler; Timo D Vloet; Nora Strom; Charlotte Jaite; Erika Graf; Viola Kappel; Andreas Warnke; Christian Jacob; Klaus Hennighausen; Barbara Haack-Dees; Katja Schneider-Momm; Swantje Matthies; Michael Rösler; Wolfgang Retz; Susann Hänig; Alexander von Gontard; Esther Sobanski; Barbara Alm; Sarah Hohmann; Luise Poustka; Michael Colla; Laura Gentschow; Christine M Freitag; Alexander Häge; Martin Holtmann; Katja Becker; Alexandra Philipsen; Thomas Jans Journal: Eur Child Adolesc Psychiatry Date: 2019-12-05 Impact factor: 4.785
Authors: Soheil Mahdi; Nadia Ronzano; Ane Knüppel; José Carlos Dias; Ayman Albdah; Lin Chien-Ho; Omar Almodayfer; Annet Bluschke; Sunil Karande; Huei-Lin Huang; Hanna Christiansen; Mats Granlund; Petrus J de Vries; David Coghill; Rosemary Tannock; Luis Rohde; Sven Bölte Journal: Eur Child Adolesc Psychiatry Date: 2018-02-17 Impact factor: 4.785
Authors: John T Mitchell; Elizabeth M McIntyre; Joseph S English; Michelle F Dennis; Jean C Beckham; Scott H Kollins Journal: J Atten Disord Date: 2013-12-04 Impact factor: 3.256